GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $768,000 | -12.6% | 13,928 | 0.0% | 0.11% | -13.0% |
| Q2 2020 | $879,000 | +23.5% | 13,928 | 0.0% | 0.12% | +16.0% |
| Q1 2020 | $712,000 | -35.7% | 13,928 | 0.0% | 0.11% | -81.8% |
| Q4 2019 | $1,107,000 | +63.8% | 13,928 | 0.0% | 0.58% | -54.9% |
| Q3 2019 | $676,000 | -7.8% | 13,928 | 0.0% | 1.29% | -37.5% |
| Q2 2019 | $733,000 | +8.9% | 13,928 | 0.0% | 2.07% | +30.7% |
| Q1 2019 | $673,000 | +17.7% | 13,928 | 0.0% | 1.58% | +14.5% |
| Q4 2018 | $572,000 | +8.1% | 13,928 | 0.0% | 1.38% | +34.4% |
| Q3 2018 | $529,000 | -16.0% | 13,928 | 0.0% | 1.03% | -37.5% |
| Q2 2018 | $630,000 | -6.4% | 13,928 | 0.0% | 1.65% | +33.5% |
| Q1 2018 | $673,000 | +22.8% | 13,928 | 0.0% | 1.23% | +49.4% |
| Q4 2017 | $548,000 | – | 13,928 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |